Disruption of B-myb in DT40 cells reveals novel function for B-Myb in the response to DNA-damage

Oncogene

Volumn 24, Issue 48, 2005, Pages 7127-7134

  Ahlbory, Dörthe ^a   Appl, Hartmut ^a   Lang, Detlef ^a   Klempnauer, Karl Heinz ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

B myb; DNA damage; DT40; Homologous recombination

Indexed keywords

DNA; DOXYCYCLINE; PROTEIN MYB;

ALKYLATION; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; GENE DISRUPTION; GENE FUNCTION; GENE TARGETING; NONHUMAN; ONCOGENE MYB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRUCTURAL HOMOLOGY; ULTRAVIOLET IRRADIATION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHICKENS; CLONE CELLS; DNA DAMAGE; DOXYCYCLINE; GENE EXPRESSION REGULATION; GENE TARGETING; GENES, MYB; GENETIC ENGINEERING; MICROARRAY ANALYSIS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYB; RECOMBINATION, GENETIC; RNA, MESSENGER; TRANSCRIPTION FACTORS; ULTRAVIOLET RAYS;

ANIMALIA; VERTEBRATA;

EID: 27944492883     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208869     Document Type: Article

References (29)

1. Appl H and Klempnauer K-H. (2002). Oncogene, 21, 3076-3081.
2. Beall EL, Manak JR, Zhou S, Bell M, Lipsick JS and Botchan MR. (2002). Nature, 420, 833-837.
3. Buerstedde JM and Takeda S. (1991). Cell, 67, 179-188.
4. Cervellera M, Raschella G, Santilli G, Tanno B, Ventura A, Mancini C, Sevignani C, Calabretta B and Sala A. (2000). J. Biol. Chem., 275, 21055-21060.
5. Cervellera MN and Sala A. (2000). J. Biol. Chem., 275, 10692-10696.
6. Davidson C, Tirouvanziam R, Herzenberg L and Lipsick J. (2004). Genetics, 169, 215-229.
7. Fitzpatrick CA, Sharkov NV, Ramsay G and Katzen AL. (2002). Development, 129, 4497-4507.
8. Foos G, Grimm S and Klempnauer K-H. (1992). EMBO J., 11, 4619-4629.
9. Foos G, Grimm S and Klempnauer K-H. (1994). Oncogene, 9, 2481-2488.
10. Grassilli E, Salomoni P, Perrotti D, Franceschi C and Calabretta B. (1999). Cancer Res., 59, 2451-2456.
11. Huber A, Bai P, de Murcia JM and de Murcia G. (2004). DNA Repair, 3, 1103-1108.
12. Joaquin M, Bessa M, Saville MK and Watson RJ. (2002). Oncogene, 21, 7923-7932.
13. Joaquin M and Watson RJ. (2003). Cell Mol. Life Sci., 60, 2389-2401.
14. Kamano H, Burk B, Noben-Trauth K and Klempnauer K-H. (1995). Oncogene, 11, 2575-2582.
15. Katzen AL, Jackson J, Harmon BP, Fung SM, Ramsay G and Bishop JM. (1998). Genes Dev., 12, 831-843.
16. Klempnauer K-H and Bishop JM. (1983). J. Virol., 4, 565-572.
17. Lam EW-F and Watson RJ. (1993). EMBO J., 12, 2705-2713.
18. Lane S, Farlie P and Watson R. (1997). Oncogene, 14, 2445-2453.
19. Lang D, Dohle F, Terstesse M, Bangen P, August C, Pauels HG and Heidenreich S. (2002). J. Immunol., 168, 6152-6158.
20. Lang G, Gombert WM and Gould HJ. (2005). Immunology, 114, 25-36.
21. Manak JR, Mitiku N and Lipsick JS. (2002). Proc. Natl. Acad. Sci. USA, 99, 7438-7443.
22. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott Jr WJ and Potter SS. (1991). Cell, 65, 677-689.
23. Neiman PE, Ruddell A, Jasoni C, Loring G, Thomas SJ, Brandvold KA, Lee R, Burnside J and Delrow J. (2001). Proc. Natl. Acad. Sci. USA, 98, 6378-6383.
24. Nyberg KA, Michelson RJ, Putnam CW and Weinert TA. (2002). Annu. Rev. Genet., 36, 617-656.
25. Sitzmann J, Noben-Trauth K, Kamano H and Klempnauer K-H. (1996). Oncogene, 12, 1889-1894.
26. Tanaka Y, Patestos NP, Maekawa T and Ishii S. (1999). J. Biol. Chem., 274, 28067-28070.
27. Toscani A, Mettus RV, Coupland R, Simpkins H, Litvin J, Orth J, Hatton KS and Reddy EP. (1997). Nature, 386, 713-717.
28. Zhu W, Giangrande PH and Nevins JR. (2004). EMBO J., 23, 4615-4626.
29. Ziebold U, Bartsch O, Marais R, Ferrari S and Klempnauer K-H. (1997). Curr. Biol., 7, 253-260.